AI and Robotics Revolutionize Prostate Care with Precision Breakthroughs

New York-based Mount Sinai Hospital’s pioneering use of the HYDROS™ Robotic System—featuring AI-guided imaging and heat-free waterjet technology—exemplifies how artificial intelligence is transforming urological care. The system enables precise BPH tissue removal with next-day discharge, mirroring broader prostate cancer advancements where AI diagnostics now achieve 95% accuracy. Robotic surgeries for both conditions reduce complications by 30-40%, preserving urinary/sexual function better than traditional methods.

Key innovations include FirstAssist AI™ for real-time surgical mapping and PSMA-targeted therapies minimizing side effects. Unlike static conventional approaches, AI-robotic systems dynamically adapt to patient anatomy and tumor biology. While adoption depends on factors like tumor genetics and healthcare access, Mount Sinai’s training initiatives aim to expand these precision treatments. Together, these technologies mark a paradigm shift toward personalized, minimally invasive care for prostate conditions affecting millions worldwide.